Cat: IPD-X27900

Recombinant Human CALML3 Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    CALML3

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 别名

    CLP; Calmodulin-related protein NB-1; CaM-like protein

  • 种属

    Human

  • 表达系统

    E. coli

  • 标签

    N-His

  • 纯度

    Greater than 95% as determined by SDS-PAGE.

  • 蛋白编号

    P27482

  • 表达区间

    Met1~Lys149

  • 分子量

    22kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

CALML3 (Calmodulin-Like Protein 3) is a member of the calmodulin superfamily, known for its role in calcium signaling and various cellular processes. Research into CALML3 has gained traction due to its potential implications in health and disease, particularly in cancer biology, neurodegenerative disorders, and heart diseases. CALML3 has been implicated in the regulation of calcium-dependent signaling pathways, influencing processes such as cell proliferation, apoptosis, and differentiation. Its ability to bind calcium ions and interact with various target proteins underscores its importance in modulating cellular functions. Additionally, abnormalities in CALML3 expression or function have been associated with pathological conditions, prompting investigations into its role as a therapeutic target or biomarker. Given the complexity of calcium signaling networks, studying CALML3 protein expression, structure, and interactions can provide insights into its physiological roles and therapeutic potential. Advances in protein engineering and recombinant DNA technology have facilitated the production of CALML3 for detailed structural and functional studies, which are essential for understanding how it contributes to health and disease. These insights could pave the way for novel treatment strategies that harness the regulatory mechanisms governed by CALML3, highlighting the importance of continued research in this area. Thus, the study of CALML3 not only enriches our understanding of calcium signaling but also opens avenues for innovative therapeutic interventions.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US